{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:09:51Z","timestamp":1784408991399,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,27]]},"DOI":"10.7759\/cureus.109779","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:41:06Z","timestamp":1779946866000},"source":"Crossref","is-referenced-by-count":1,"title":["Progressive Supranuclear Palsy Unmasked After Post-COVID-19 Functional Decline in an Elderly Patient: A Diagnostic Challenge"],"prefix":"10.7759","author":[{"given":"Enrico","family":"Fulco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"H\u00f6glinger GU","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, et al.. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017, 32:853-64. 10.1002\/mds.26987","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2020-002794","article-title":"Progressive supranuclear palsy: diagnosis and management","volume":"21","author":"Rowe JB","year":"2021","unstructured":"Rowe JB, Holland N, Rittman T. Progressive supranuclear palsy: diagnosis and management. Pract Neurol. 2021, 21:376-83. 10.1136\/practneurol-2020-002794","journal-title":"Pract Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-017-1812-4","article-title":"Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy","volume":"59","author":"Sakurai K","year":"2017","unstructured":"Sakurai K, Tokumaru AM, Shimoji K, et al.. Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. Neuroradiology. 2017, 59:431-43. 10.1007\/s00234-017-1812-4","journal-title":"Neuroradiology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27038","article-title":"Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?","volume":"32","author":"Whitwell JL","year":"2017","unstructured":"Whitwell JL, H\u00f6glinger GU, Antonini A, et al.. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?. Mov Disord. 2017, 32:955-71. 10.1002\/mds.27038","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318292a2d2","article-title":"The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy","volume":"80","author":"Massey LA","year":"2013","unstructured":"Massey LA, J\u00e4ger HR, Paviour DC, et al.. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology. 2013, 80:1856-61. 10.1212\/WNL.0b013e318292a2d2","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1172416","article-title":"COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection","volume":"14","author":"Iacono S","year":"2023","unstructured":"Iacono S, Schir\u00f2 G, Dav\u00ec C, et al.. COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection. Front Neurol. 2023, 14:1172416. 10.3389\/fneur.2023.1172416","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0500","article-title":"How COVID-19 affects the brain","volume":"78","author":"Boldrini M","year":"2021","unstructured":"Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiatry. 2021, 78:682-3. 10.1001\/jamapsychiatry.2021.0500","journal-title":"JAMA Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2014.09.012","article-title":"Atypical parkinsonism: diagnosis and treatment","volume":"33","author":"Stamelou M","year":"2015","unstructured":"Stamelou M, Bhatia KP. Atypical parkinsonism: diagnosis and treatment. Neurol Clin. 2015, 33:39-56. 10.1016\/j.ncl.2014.09.012","journal-title":"Neurol Clin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.4347","article-title":"Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome","volume":"77","author":"Jabbari E","year":"2020","unstructured":"Jabbari E, Holland N, Chelban V, et al.. Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome. JAMA Neurol. 2020, 77:377-87. 10.1001\/jamaneurol.2019.4347","journal-title":"JAMA Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","author":"Boxer AL","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI, et al.. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol. 2017, 16:552-63. 10.1016\/S1474-4422(17)30157-6","journal-title":"Lancet Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496692-progressive-supranuclear-palsy-unmasked-after-post-covid-19-functional-decline-in-an-elderly-patient-a-diagnostic-challenge","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:41:07Z","timestamp":1779946867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496692-progressive-supranuclear-palsy-unmasked-after-post-covid-19-functional-decline-in-an-elderly-patient-a-diagnostic-challenge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.109779","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}